These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 16300848
1. Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92. Timmermann B, Kortmann RD, Kühl J, Rutkowski S, Dieckmann K, Meisner C, Bamberg M. Radiother Oncol; 2005 Dec; 77(3):278-85. PubMed ID: 16300848 [Abstract] [Full Text] [Related]
2. Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. Timmermann B, Kortmann RD, Kühl J, Rutkowski S, Meisner C, Pietsch T, Deinlein F, Urban C, Warmuth-Metz M, Bamberg M. J Clin Oncol; 2006 Apr 01; 24(10):1554-60. PubMed ID: 16575007 [Abstract] [Full Text] [Related]
3. Ependymal tumors in childhood. Agaoglu FY, Ayan I, Dizdar Y, Kebudi R, Gorgun O, Darendeliler E. Pediatr Blood Cancer; 2005 Sep 01; 45(3):298-303. PubMed ID: 15770637 [Abstract] [Full Text] [Related]
4. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Massimino M, Gandola L, Giangaspero F, Sandri A, Valagussa P, Perilongo G, Garrè ML, Ricardi U, Forni M, Genitori L, Scarzello G, Spreafico F, Barra S, Mascarin M, Pollo B, Gardiman M, Cama A, Navarria P, Brisigotti M, Collini P, Balter R, Fidani P, Stefanelli M, Burnelli R, Potepan P, Podda M, Sotti G, Madon E, AIEOP Pediatric Neuro-Oncology Group. Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1336-45. PubMed ID: 15050308 [Abstract] [Full Text] [Related]
5. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH). Gnekow AK, Kortmann RD, Pietsch T, Emser A. Klin Padiatr; 2004 Apr 01; 216(6):331-42. PubMed ID: 15565548 [Abstract] [Full Text] [Related]
6. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group. J Clin Oncol; 2005 Oct 20; 23(30):7621-31. PubMed ID: 16234523 [Abstract] [Full Text] [Related]
7. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A, Finlay J. Pediatr Blood Cancer; 2007 Jul 20; 49(1):34-40. PubMed ID: 16874765 [Abstract] [Full Text] [Related]
8. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Needle MN, Goldwein JW, Grass J, Cnaan A, Bergman I, Molloy P, Sutton L, Zhao H, Garvin JH, Phillips PC. Cancer; 1997 Jul 15; 80(2):341-7. PubMed ID: 9217048 [Abstract] [Full Text] [Related]
9. Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database. Benesch M, Weber-Mzell D, Gerber NU, von Hoff K, Deinlein F, Krauss J, Warmuth-Metz M, Kortmann RD, Pietsch T, Driever PH, Quehenberger F, Urban C, Rutkowski S. J Neurosurg Pediatr; 2010 Aug 15; 6(2):137-44. PubMed ID: 20672934 [Abstract] [Full Text] [Related]
10. Salvage treatment for childhood ependymoma after surgery only: Pitfalls of omitting "at once" adjuvant treatment. Massimino M, Giangaspero F, Garrè ML, Genitori L, Perilongo G, Collini P, Riva D, Valentini L, Scarzello G, Poggi G, Spreafico F, Peretta P, Mascarin M, Modena P, Sozzi G, Bedini N, Biassoni V, Urgesi A, Balestrini MR, Finocchiaro G, Sandri A, Gandola L, AIEOP Neuro-Oncology Group. Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1440-5. PubMed ID: 16863927 [Abstract] [Full Text] [Related]
11. A multicenter study of the prognosis and treatment of adult brain ependymal tumors. Reni M, Brandes AA, Vavassori V, Cavallo G, Casagrande F, Vastola F, Magli A, Franzin A, Basso U, Villa E. Cancer; 2004 Mar 15; 100(6):1221-9. PubMed ID: 15022290 [Abstract] [Full Text] [Related]
12. Childhood intracranial ependymoma: twenty-year experience from a single institution. Shu HK, Sall WF, Maity A, Tochner ZA, Janss AJ, Belasco JB, Rorke-Adams LB, Phillips PC, Sutton LN, Fisher MJ. Cancer; 2007 Jul 15; 110(2):432-41. PubMed ID: 17559078 [Abstract] [Full Text] [Related]
13. Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy. Conter C, Carrie C, Bernier V, Geoffray A, Pagnier A, Gentet JC, Lellouch-Tubiana A, Chabaud S, Frappaz D. Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1536-42. PubMed ID: 19362789 [Abstract] [Full Text] [Related]
14. Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy. Massimino M, Gandola L, Barra S, Giangaspero F, Casali C, Potepan P, Di Rocco C, Nozza P, Collini P, Viscardi E, Bertin D, Biassoni V, Cama A, Milanaccio C, Modena P, Balter R, Tamburrini G, Peretta P, Mascarin M, Scarzello G, Fidani P, Milano GM, Sardi I, Genitori L, Garrè ML. Int J Radiat Oncol Biol Phys; 2011 Jul 01; 80(3):807-14. PubMed ID: 20646868 [Abstract] [Full Text] [Related]
16. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology. Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C, French Society of Pediatric Oncology. J Clin Oncol; 2003 Dec 15; 21(24):4572-8. PubMed ID: 14673044 [Abstract] [Full Text] [Related]
17. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma. Sieniawski M, Franklin J, Nogova L, Glossmann JP, Schober T, Nisters-Backes H, Diehl V, Josting A. J Clin Oncol; 2007 May 20; 25(15):2000-5. PubMed ID: 17420510 [Abstract] [Full Text] [Related]
18. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor. Paulino AC, Cha DT, Barker JL, Lo S, Manera RB. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1171-6. PubMed ID: 15001261 [Abstract] [Full Text] [Related]
19. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR, Milstein JM, Packer RJ, Wisoff J. J Neurosurg; 1998 Apr 15; 88(4):695-703. PubMed ID: 9525716 [Abstract] [Full Text] [Related]
20. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ. Pediatr Blood Cancer; 2007 Mar 15; 48(3):278-84. PubMed ID: 16456857 [Abstract] [Full Text] [Related] Page: [Next] [New Search]